Lisa Norquay

803 total citations
19 papers, 387 citations indexed

About

Lisa Norquay is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lisa Norquay has authored 19 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Lisa Norquay's work include Pancreatic function and diabetes (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Lisa Norquay is often cited by papers focused on Pancreatic function and diabetes (6 papers), Growth Hormone and Insulin-like Growth Factors (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Lisa Norquay collaborates with scholars based in United States, Canada and Spain. Lisa Norquay's co-authors include Morris F. White, Katharine D’Aquino, Marianna Sadagurski, Peter A. Cattini, Kyle D. Copps, Kazuya Yamagata, Bernard Zinman, R. D. Kirkpatrick, Anthony J. Hanley and P. Hugh R. Barrett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Diabetes.

In The Last Decade

Lisa Norquay

19 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Norquay United States 10 162 105 105 100 97 19 387
Erwin Reiling Netherlands 12 271 1.7× 144 1.4× 179 1.7× 77 0.8× 114 1.2× 17 575
Marisela Villalobos‐Comparán Mexico 8 124 0.8× 72 0.7× 128 1.2× 54 0.5× 61 0.6× 9 367
Amy Fleischman United States 7 160 1.0× 115 1.1× 107 1.0× 220 2.2× 138 1.4× 8 513
A. Hugill United Kingdom 4 200 1.2× 71 0.7× 77 0.7× 39 0.4× 116 1.2× 5 394
Dean P. Larner United Kingdom 10 130 0.8× 217 2.1× 46 0.4× 65 0.7× 107 1.1× 18 476
Roxana Gutiérrez‐Vidal Mexico 9 129 0.8× 78 0.7× 67 0.6× 175 1.8× 89 0.9× 14 374
Daniela Vejražková Czechia 13 97 0.6× 100 1.0× 80 0.8× 32 0.3× 81 0.8× 36 400
Martina Škopková Slovakia 12 171 1.1× 135 1.3× 192 1.8× 49 0.5× 77 0.8× 31 438
Uğur Hodoğlugil United States 14 118 0.7× 87 0.8× 110 1.0× 27 0.3× 112 1.2× 32 447
Émilie Pépin Canada 8 168 1.0× 121 1.2× 87 0.8× 42 0.4× 103 1.1× 10 365

Countries citing papers authored by Lisa Norquay

Since Specialization
Citations

This map shows the geographic impact of Lisa Norquay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Norquay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Norquay more than expected).

Fields of papers citing papers by Lisa Norquay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Norquay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Norquay. The network helps show where Lisa Norquay may publish in the future.

Co-authorship network of co-authors of Lisa Norquay

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Norquay. A scholar is included among the top collaborators of Lisa Norquay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Norquay. Lisa Norquay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Steffen, Janos, Jennifer Ngo, Sheng-Ping Wang, et al.. (2022). The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR. Molecular Metabolism. 64. 101566–101566. 32 indexed citations
2.
Liu, Jianying, Hui Huang, Jenson Qi, et al.. (2022). A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates. Frontiers in Endocrinology. 13. 1061688–1061688. 7 indexed citations
3.
Kang, Lijuan, Wilson B. Edwards, Raul C. Camacho, et al.. (2021). Application of Middle-Down Approach in Quantitation and Catabolite Identification of Protein by LC–high-Resolution Mass Spectrometry. Bioanalysis. 13(6). 465–479. 1 indexed citations
4.
Zhang, Xuqing, Bin Zhu, Lili Guo, et al.. (2021). Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 47. 128172–128172. 4 indexed citations
5.
Zhu, Bin, Xuqing Zhang, Lili Guo, et al.. (2021). Discovery and Optimization of 7-Alkylidenyltetrahydroindazole-Based Acylsulfonamide EP3 Antagonists. ACS Medicinal Chemistry Letters. 13(1). 111–117. 1 indexed citations
6.
Zhang, Xuqing, Bin Zhu, Lili Guo, et al.. (2021). Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes. ACS Medicinal Chemistry Letters. 12(3). 451–458. 4 indexed citations
7.
Shi, Yifan, Matthew M. Rankin, Lisa Norquay, Naidong Weng, & Shefali Patel. (2018). Bioanalysis of sulprostone, a prostaglandin E2 analogue and selective EP3 agonist, in monkey plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 1092. 51–57. 3 indexed citations
8.
Liu, Jianying, Tonya Martin, Sanath K. Meegalla, et al.. (2018). FFAR1 Agonism Restores Insulin Secretion in Rodents, Human Islets, and Diabetic Monkeys. Diabetes. 67(Supplement_1). 1 indexed citations
9.
Rankin, Matthew M., Lili Guo, Shuyuan Zhao, et al.. (2018). Therapeutic Potential of EP3 Receptor Antagonists for Treatment of Noninsulin Dependent Diabetes Mellitus across Multiple Preclinical Models. Diabetes. 67(Supplement_1). 2 indexed citations
10.
Kuznetsova, Alexandra, Yue Yu, Jennifer Hollister‐Lock, et al.. (2016). Trimeprazine increases IRS2 in human islets and promotes pancreatic β cell growth and function in mice. JCI Insight. 1(3). 5 indexed citations
11.
Gutteridge, Alex, J. Michael Rukstalis, Daniel Ziemek, et al.. (2013). Novel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning. PLoS ONE. 8(2). e56024–e56024. 12 indexed citations
12.
Sadagurski, Marianna, et al.. (2009). Human IL6 enhances leptin action in mice. Diabetologia. 53(3). 525–535. 128 indexed citations
13.
Norquay, Lisa, Katharine D’Aquino, Alexandra Kuznetsova, et al.. (2009). Insulin Receptor Substrate-2 in β-Cells Decreases Diabetes in Nonobese Diabetic Mice. Endocrinology. 150(10). 4531–4540. 20 indexed citations
14.
Norquay, Lisa, Xiaoyang Yang, Yan Jin, Karen A. Detillieux, & Peter A. Cattini. (2005). Hepatocyte Nuclear Factor-3α Binding at P Sequences of the Human Growth Hormone Locus Is Associated with Pituitary Repressor Function. Molecular Endocrinology. 20(3). 598–607. 19 indexed citations
15.
16.
Norquay, Lisa, Xiaoyong Yang, Patricia Sheppard, et al.. (2003). RFX1 and NF-1 Associate with P Sequences of the Human Growth Hormone Locus in Pituitary Chromatin. Molecular Endocrinology. 17(6). 1027–1038. 19 indexed citations
17.
Triggs‐Raine, Barbara L., R. D. Kirkpatrick, Sherrie L. Kelly, et al.. (2002). HNF-1α G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proceedings of the National Academy of Sciences. 99(7). 4614–4619. 88 indexed citations
18.
Norquay, Lisa, et al.. (2001). A member of the nuclear factor-1 family is involved in the pituitary repression of the human placental growth hormone genes. Biochemical Journal. 354(2). 387–387. 18 indexed citations
19.
Norquay, Lisa, et al.. (2001). A member of the nuclear factor-1 family is involved in the pituitary repression of the human placental growth hormone genes. Biochemical Journal. 354(2). 387–395. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwin Reiling Breakdown of academic impact, for papers by Marisela Villalobos‐Comparán Breakdown of academic impact, for papers by Amy Fleischman Breakdown of academic impact, for papers by A. Hugill Breakdown of academic impact, for papers by Dean P. Larner Breakdown of academic impact, for papers by Roxana Gutiérrez‐Vidal Breakdown of academic impact, for papers by Daniela Vejražková Breakdown of academic impact, for papers by Martina Škopková Breakdown of academic impact, for papers by Uğur Hodoğlugil Breakdown of academic impact, for papers by Émilie Pépin
Rankless by CCL
2026